New study combines HIV prevention and opioid care at local pharmacies

NCT ID NCT07160075

Recruiting now Prevention Sponsor: Cara Spence Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether giving HIV prevention pills (PrEP) at the same time as opioid addiction treatment in pharmacies is practical and acceptable. About 350 HIV-negative adults on opioid therapy in Alberta and Saskatchewan will take part. Researchers will track how many people start and continue PrEP, and also ask about interest in long-acting injectable HIV prevention.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV (HUMAN IMMUNODEFICIENCY VIRUS)

Contacts and locations

Locations

Mayfair Drugs Pharmacy
RECRUITING

Saskatoon, Saskatchewan, S7L 0V8, Canada
Meadowgreen Pharmacy
RECRUITING

Saskatoon, Saskatchewan, S7M 4R5, Canada
Pharmasave Riversdale Pharmacy
RECRUITING

Saskatoon, Saskatchewan, S7M 0Y2, Canada
Queen City Wellness Pharmacy
NOT_YET_RECRUITING

Regina, Saskatchewan, S4P 0H7, Canada
Sheldon M Chumir Health Centre
NOT_YET_RECRUITING

Calgary, Alberta, T2R 0X7, Canada
The Medicine Shoppe Pharmacy
RECRUITING

Saskatoon, Saskatchewan, S7M 0Z7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.